Cargando…

Immune profiling in human breast cancer using high-sensitivity detection and analysis techniques

OBJECTIVES: Evaluation of immune profiles in human breast cancer using high-sensitivity detection and analysis methods. DESIGN: Cohort comparative analysis studies of breast tissue. SETTING: Human hospital and laboratory healthcare facilities. PARTICIPANTS: Women over 18 years. MAIN OUTCOME MEASURES...

Descripción completa

Detalles Bibliográficos
Autores principales: Coventry, Brendon J, Weightman, Michael J, Bradley, John, Skinner, John M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4589078/
https://www.ncbi.nlm.nih.gov/pubmed/26464809
http://dx.doi.org/10.1177/2054270415603909
_version_ 1782392740961583104
author Coventry, Brendon J
Weightman, Michael J
Bradley, John
Skinner, John M
author_facet Coventry, Brendon J
Weightman, Michael J
Bradley, John
Skinner, John M
author_sort Coventry, Brendon J
collection PubMed
description OBJECTIVES: Evaluation of immune profiles in human breast cancer using high-sensitivity detection and analysis methods. DESIGN: Cohort comparative analysis studies of breast tissue. SETTING: Human hospital and laboratory healthcare facilities. PARTICIPANTS: Women over 18 years. MAIN OUTCOME MEASURES: Evaluation of the comparative immunophenotype of human breast carcinoma and normal breast tissues. RESULTS: Leukocyte density and specific subgroups of lymphocytes and macrophages were generally higher in breast cancers compared to normal breast tissues. CD3, CD4, CD45RO, CD45RA(2H4), CD45 and HLA Class II (on TIL) were significantly expressed on breast tumour tissues compared with normal tissues (p < .01). Some 30% of T-cells were γδ-TCR positive, but the majority were αβ-TCR in type. CD19 (B-cell), CD14 (FMC32 and 33) and HLA Class I levels (epithelial and TIL) showed no significant differences. IL-2α receptor expression was low or absent on most TIL. CONCLUSIONS: High-sensitivity and image analysis techniques permitted accurate characterisation of the TIL infiltrate for immune profiling. Breast carcinoma showed predominance of CD4 T-cells of mainly memory phenotype. Normal breast tissues showed low leukocyte infiltration. Further correlation of these findings with clinical outcome, including survival, is proceeding with encouraging results.
format Online
Article
Text
id pubmed-4589078
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-45890782015-10-13 Immune profiling in human breast cancer using high-sensitivity detection and analysis techniques Coventry, Brendon J Weightman, Michael J Bradley, John Skinner, John M JRSM Open Research OBJECTIVES: Evaluation of immune profiles in human breast cancer using high-sensitivity detection and analysis methods. DESIGN: Cohort comparative analysis studies of breast tissue. SETTING: Human hospital and laboratory healthcare facilities. PARTICIPANTS: Women over 18 years. MAIN OUTCOME MEASURES: Evaluation of the comparative immunophenotype of human breast carcinoma and normal breast tissues. RESULTS: Leukocyte density and specific subgroups of lymphocytes and macrophages were generally higher in breast cancers compared to normal breast tissues. CD3, CD4, CD45RO, CD45RA(2H4), CD45 and HLA Class II (on TIL) were significantly expressed on breast tumour tissues compared with normal tissues (p < .01). Some 30% of T-cells were γδ-TCR positive, but the majority were αβ-TCR in type. CD19 (B-cell), CD14 (FMC32 and 33) and HLA Class I levels (epithelial and TIL) showed no significant differences. IL-2α receptor expression was low or absent on most TIL. CONCLUSIONS: High-sensitivity and image analysis techniques permitted accurate characterisation of the TIL infiltrate for immune profiling. Breast carcinoma showed predominance of CD4 T-cells of mainly memory phenotype. Normal breast tissues showed low leukocyte infiltration. Further correlation of these findings with clinical outcome, including survival, is proceeding with encouraging results. SAGE Publications 2015-09-22 /pmc/articles/PMC4589078/ /pubmed/26464809 http://dx.doi.org/10.1177/2054270415603909 Text en © The Author(s) 2015 http://creativecommons.org/licenses/by-nc/3.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page(https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Research
Coventry, Brendon J
Weightman, Michael J
Bradley, John
Skinner, John M
Immune profiling in human breast cancer using high-sensitivity detection and analysis techniques
title Immune profiling in human breast cancer using high-sensitivity detection and analysis techniques
title_full Immune profiling in human breast cancer using high-sensitivity detection and analysis techniques
title_fullStr Immune profiling in human breast cancer using high-sensitivity detection and analysis techniques
title_full_unstemmed Immune profiling in human breast cancer using high-sensitivity detection and analysis techniques
title_short Immune profiling in human breast cancer using high-sensitivity detection and analysis techniques
title_sort immune profiling in human breast cancer using high-sensitivity detection and analysis techniques
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4589078/
https://www.ncbi.nlm.nih.gov/pubmed/26464809
http://dx.doi.org/10.1177/2054270415603909
work_keys_str_mv AT coventrybrendonj immuneprofilinginhumanbreastcancerusinghighsensitivitydetectionandanalysistechniques
AT weightmanmichaelj immuneprofilinginhumanbreastcancerusinghighsensitivitydetectionandanalysistechniques
AT bradleyjohn immuneprofilinginhumanbreastcancerusinghighsensitivitydetectionandanalysistechniques
AT skinnerjohnm immuneprofilinginhumanbreastcancerusinghighsensitivitydetectionandanalysistechniques